InMed Pharmaceuticals Inc.
INM
$2.12
-$0.23-9.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 68.10% | -38.24% | -63.88% | -17.03% | -26.15% |
| Total Receivables | 31.83% | 77.08% | -29.58% | 71.61% | 35.48% |
| Inventory | -22.75% | -31.83% | 48.15% | 7.68% | -23.02% |
| Prepaid Expenses | -32.66% | -50.14% | -42.14% | -30.74% | -4.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 48.08% | -36.31% | -53.68% | -12.24% | -23.32% |
|
|
|||||
| Total Current Assets | 48.08% | -36.31% | -53.68% | -12.24% | -23.32% |
| Net Property, Plant & Equipment | -20.62% | -19.13% | -16.89% | 118.34% | 72.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.12% | -8.92% | -8.75% | -8.56% | -8.38% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -1.77% | -4.67% |
| Total Assets | 31.78% | -30.53% | -44.27% | -4.14% | -16.19% |
|
|
|||||
| Total Accounts Payable | -40.90% | 39.05% | 87.47% | 18.19% | 15.07% |
| Total Accrued Expenses | 4.72% | 16.56% | -10.80% | -15.88% | -7.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.04% | 24.23% | 15.24% | 44.81% | -15.41% |
| Total Finance Division Other Current Liabilities | -98.29% | -93.22% | -90.57% | -- | 153.09% |
| Total Other Current Liabilities | -98.29% | -93.22% | -90.57% | -- | 153.09% |
| Total Current Liabilities | -6.69% | 20.29% | 6.57% | 7.22% | -1.44% |
|
|
|||||
| Total Current Liabilities | -6.69% | 20.29% | 6.57% | 7.22% | -1.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -52.58% | -42.18% | -34.08% | -- | 3,930.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -18.01% | 0.19% | -6.57% | 54.55% | 29.76% |
|
|
|||||
| Common Stock & APIC | 10.49% | 3.58% | 1.12% | 4.97% | 4.23% |
| Retained Earnings | -7.48% | -7.76% | -7.51% | -6.56% | -7.57% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 45.93% | -36.77% | -51.60% | -12.35% | -23.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.93% | -36.77% | -51.60% | -12.35% | -23.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.93% | -36.77% | -51.60% | -12.35% | -23.85% |
|
|
|||||